Annual Drug Patent Expirations for ONUREG
Onureg is a drug marketed by Bristol and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
This drug has sixty-seven patent family members in thirty-five countries.
The generic ingredient in ONUREG is azacitidine. One supplier is listed for this compound. Additional details are available on the azacitidine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com